Teva Biological Technology

Teva Pharmaceutical Industries Ltd. in Vietnam:

Factory or Trader: Primarily a trader (marketer and distributor).

Company Profile:

Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company headquartered in Israel. In Vietnam, Teva operates through its representative office, focusing on the marketing, sales, and distribution of its diverse portfolio of generic medicines, specialty products, and biopharmaceuticals. While "Biological Technology" is a significant area of focus for Teva's global research, development, and product pipeline, the entity in Vietnam serves primarily as a commercial operation for the imported products rather than a manufacturing facility. Teva's manufacturing plants are located in various countries worldwide, not typically in Vietnam. Their role in Vietnam is to ensure their pharmaceutical products are accessible in the local market through established distribution channels.

The company "Teva Biological Technology" as a distinct entity in Vietnam is not widely identified. However, Teva Pharmaceutical Industries, a global pharmaceutical company with a presence in Vietnam, has a global portfolio that includes biological technology products, specifically biosimilars.

Products from Teva's global biosimilar portfolio that align with "biological technology" include:

Truxima (rituximab biosimilar): Used for conditions such as non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis.

Herzuma (trastuzumab biosimilar): Used for the treatment of HER2-positive breast cancer and gastric cancer.

The availability and distribution of these specific biosimilar products in Vietnam depend on local regulatory approvals and Teva's commercialization strategies within the country.